Human immunodeficiency virus 1 envelope glycoprotein (env) gene, parti - PopSet

HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy. [PLoS One. 2009]
HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.
Mavigner M, Delobel P, Cazabat M, Dubois M, L'faqihi-Olive FE, Raymond S, Pasquier C, Marchou B, Massip P, Izopet J. PLoS One. 2009 Oct 30; 4(10):e7658. Epub 2009 Oct 30.

Human immunodeficiency virus 1 envelope glycoprotein (env) gene, partial cds.
Human immunodeficiency virus 1 envelope glycoprotein (env) gene, partial cds.
population study, 127 sequences
Human immunodeficiency virus 1 envelope glycoprotein (env) gene, partial cds.
Human immunodeficiency virus 1 envelope glycoprotein (env) gene, partial cds.
population study, 15 sequences
Human immunodeficiency virus 1 envelope glycoprotein (env) gene, partial cds.
Human immunodeficiency virus 1 envelope glycoprotein (env) gene, partial cds.
population study, 43 sequences
Human immunodeficiency virus 1 envelope glycoprotein (env) gene, partial cds.
Human immunodeficiency virus 1 envelope glycoprotein (env) gene, partial cds.
population study, 147 sequences
Human immunodeficiency virus 1 envelope glycoprotein (env) gene, partial cds.
Human immunodeficiency virus 1 envelope glycoprotein (env) gene, partial cds.
population study, 116 sequences

Your browsing activity is empty.

Activity recording is turned off.

PopSet